These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27650435)

  • 1. Decreased levels of NMDA but not AMPA receptors in the lipid-raft fraction of 3xTg-AD model of Alzheimer's disease: Relation to Arc/Arg3.1 protein expression.
    Morin JP; Díaz-Cintra S; Bermúdez-Rattoni F; Delint-Ramírez I
    Neurochem Int; 2016 Nov; 100():159-163. PubMed ID: 27650435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
    Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
    Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GluN2B-Containing NMDA Receptors Regulate AMPA Receptor Traffic through Anchoring of the Synaptic Proteasome.
    Ferreira JS; Schmidt J; Rio P; Águas R; Rooyakkers A; Li KW; Smit AB; Craig AM; Carvalho AL
    J Neurosci; 2015 Jun; 35(22):8462-79. PubMed ID: 26041915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
    Xu Y; Chen P; Wang X; Yao J; Zhuang S
    Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dcf1 Affects Memory and Anxiety by Regulating NMDA and AMPA Receptors.
    Wang Y; Liu Q; Xie J; Feng R; Ma F; Wang F; Shen S; Wen T
    Neurochem Res; 2019 Nov; 44(11):2499-2505. PubMed ID: 31531752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
    Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
    Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.
    Deng Y; Wei J; Cheng J; Zhong P; Xiong Z; Liu A; Lin L; Chen S; Yan Z
    J Alzheimers Dis; 2016 Jun; 53(4):1419-32. PubMed ID: 27372643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
    Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
    J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease.
    Xu L; Ren Z; Chow FE; Tsai R; Liu T; Rizzolio F; Boffo S; Xu Y; Huang S; Lippa CF; Gong Y
    Neural Plast; 2017; 2017():3270725. PubMed ID: 28458925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease.
    Rodriguez-Ortiz CJ; Prieto GA; Martini AC; Forner S; Trujillo-Estrada L; LaFerla FM; Baglietto-Vargas D; Cotman CW; Kitazawa M
    Aging Cell; 2020 Mar; 19(3):e13118. PubMed ID: 32087004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
    Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D
    J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis.
    Antonini A; Caioli S; Saba L; Vindigni G; Biocca S; Canu N; Zona C
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):509-519. PubMed ID: 29154925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors.
    Shepherd JD; Rumbaugh G; Wu J; Chowdhury S; Plath N; Kuhl D; Huganir RL; Worley PF
    Neuron; 2006 Nov; 52(3):475-84. PubMed ID: 17088213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanistic link between Arc/Arg3.1 expression and AMPA receptor endocytosis.
    Wall MJ; Corrêa SAL
    Semin Cell Dev Biol; 2018 May; 77():17-24. PubMed ID: 28890421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-induced rapid induction of Arc/Arg3.1 requires NMDA receptor-mediated phosphorylation of ERK and CREB.
    Chen T; Zhu J; Yang LK; Feng Y; Lin W; Wang YH
    Neurosci Lett; 2017 Nov; 661():23-28. PubMed ID: 28919534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of postsynaptic density proteins: glutamate receptor subunits and scaffolding proteins.
    Shinohara Y
    Hippocampus; 2012 May; 22(5):942-53. PubMed ID: 21594948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arc ubiquitination in synaptic plasticity.
    Mabb AM; Ehlers MD
    Semin Cell Dev Biol; 2018 May; 77():10-16. PubMed ID: 28890418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA and AMPA receptors dysregulation in Alzheimer's disease.
    Babaei P
    Eur J Pharmacol; 2021 Oct; 908():174310. PubMed ID: 34265291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.